Intragam® 10 is indicated for replacement IgG therapy in:
Primary Immunodeficiency Diseases (PID)
Symptomatic hypogammaglobulinaemia secondary to underlying disease or treatment.
Intragam® 10 is indicated for immunomodulatory therapy in:
Idiopathic Thrombocytopenic Purpura (ITP), in adults or children at high risk of bleeding
or prior to surgery to correct the platelet count
Kawasaki diseaseGuillain-Barre Syndrome (GBS)
Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
Multifocal Motor Neuropathy (MMN)
Myasthenia Gravis (MG) in acute exacerbation (myasthenic crisis) or prior to surgery
and/or thymectomy; as maintenance therapy for moderate to severe MG when other
treatments have been ineffective or caused intolerable side effects
Short-term therapy for severely affected nonparaneoplastic
Lambert-Eaton Myasthenic Syndrome (LEMS) patients
Treatment of significant functional impairment in patients who have a verified diagnosis
of stiff person syndrome.
How to take it
The way to take this medicine is: Intravenous.
This medicine or fluids is given through a needle or tube (catheter) inserted into a vein.
Store at 2 to 8 degrees Celsius
Protect from Light
Shelf lifetime is 2 Years.
You should seek medical advice in relation to medicines and use only as directed by a healthcare professional.
Always read the label. If symptoms persist see your healthcare professional.
Visual appearance
Clear or slightly opalescent, colourless to pale yellow solution
Do I need a prescription?
This medicine is available from a pharmacist and requires a prescription. It is
Schedule 4 : Prescription Only Medicine.
Intragam® 10 is indicated for replacement IgG therapy in:
Primary Immunodeficiency Diseases (PID)
Symptomatic hypogammaglobulinaemia secondary to underlying disease or treatment.
Intragam® 10 is indicated for immunomodulatory therapy in:
Idiopathic Thrombocytopenic Purpura (ITP), in adults or children at high risk of bleeding
or prior to surgery to correct the platelet count
Kawasaki diseaseGuillain-Barre Syndrome (GBS)
Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
Multifocal Motor Neuropathy (MMN)
Myasthenia Gravis (MG) in acute exacerbation (myasthenic crisis) or prior to surgery
and/or thymectomy; as maintenance therapy for moderate to severe MG when other
treatments have been ineffective or caused intolerable side effects
Short-term therapy for severely affected nonparaneoplastic
Lambert-Eaton Myasthenic Syndrome (LEMS) patients
Treatment of significant functional impairment in patients who have a verified diagnosis
of stiff person syndrome.
How to take it
The way to take this medicine is: Intravenous.
This medicine or fluids is given through a needle or tube (catheter) inserted into a vein.
Store at 2 to 8 degrees Celsius
Protect from Light
Shelf lifetime is 2 Years.
You should seek medical advice in relation to medicines and use only as directed by a healthcare professional.
Always read the label. If symptoms persist see your healthcare professional.
Visual appearance
Clear or slightly opalescent, colourless to pale yellow solution
Do I need a prescription?
This medicine is available from a pharmacist and requires a prescription. It is
Schedule 4 : Prescription Only Medicine.
Intragam® 10 is indicated for replacement IgG therapy in:
Primary Immunodeficiency Diseases (PID)
Symptomatic hypogammaglobulinaemia secondary to underlying disease or treatment.
Intragam® 10 is indicated for immunomodulatory therapy in:
Idiopathic Thrombocytopenic Purpura (ITP), in adults or children at high risk of bleeding
or prior to surgery to correct the platelet count
Kawasaki diseaseGuillain-Barre Syndrome (GBS)
Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
Multifocal Motor Neuropathy (MMN)
Myasthenia Gravis (MG) in acute exacerbation (myasthenic crisis) or prior to surgery
and/or thymectomy; as maintenance therapy for moderate to severe MG when other
treatments have been ineffective or caused intolerable side effects
Short-term therapy for severely affected nonparaneoplastic
Lambert-Eaton Myasthenic Syndrome (LEMS) patients
Treatment of significant functional impairment in patients who have a verified diagnosis
of stiff person syndrome.
How to take it
The way to take this medicine is: Intravenous.
This medicine or fluids is given through a needle or tube (catheter) inserted into a vein.
Store at 2 to 8 degrees Celsius
Protect from Light
Shelf lifetime is 2 Years.
You should seek medical advice in relation to medicines and use only as directed by a healthcare professional.
Always read the label. If symptoms persist see your healthcare professional.
Visual appearance
Clear or slightly opalescent, colourless to pale yellow solution
Do I need a prescription?
This medicine is available from a pharmacist and requires a prescription. It is
Schedule 4 : Prescription Only Medicine.
